A detailed history of Hsbc Holdings PLC transactions in Opti Nose, Inc. stock. As of the latest transaction made, Hsbc Holdings PLC holds 21,745 shares of OPTN stock, worth $9,132. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,745
Previous 29,979 27.47%
Holding current value
$9,132
Previous $31,000 54.84%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.67 - $1.27 $5,516 - $10,457
-8,234 Reduced 27.47%
21,745 $14,000
Q2 2024

Aug 12, 2024

SELL
$0.82 - $1.44 $250 - $440
-306 Reduced 1.01%
29,979 $31,000
Q1 2024

May 15, 2024

BUY
$1.17 - $1.94 $9,719 - $16,115
8,307 Added 37.8%
30,285 $44,000
Q4 2023

Feb 12, 2024

BUY
$1.02 - $1.47 $241 - $348
237 Added 1.09%
21,978 $28,000
Q4 2022

Feb 14, 2023

SELL
$1.68 - $3.7 $7,010 - $15,440
-4,173 Reduced 16.1%
21,741 $40,000
Q3 2022

Nov 14, 2022

SELL
$3.43 - $4.01 $16,282 - $19,035
-4,747 Reduced 15.48%
25,914 $94,000
Q2 2022

Aug 11, 2022

SELL
$1.76 - $3.82 $11,733 - $25,467
-6,667 Reduced 17.86%
30,661 $111,000
Q4 2021

Feb 11, 2022

SELL
$1.55 - $3.1 $12 - $24
-8 Reduced 0.02%
37,328 $60,000
Q3 2021

Nov 12, 2021

BUY
$2.35 - $3.16 $36,521 - $49,109
15,541 Added 71.31%
37,336 $110,000
Q2 2021

Aug 13, 2021

BUY
$2.91 - $3.83 $23 - $30
8 Added 0.04%
21,795 $67,000
Q1 2021

May 14, 2021

SELL
$3.47 - $4.75 $3,574 - $4,892
-1,030 Reduced 4.51%
21,787 $80,000
Q4 2020

Feb 12, 2021

BUY
$3.2 - $4.98 $3,296 - $5,129
1,030 Added 4.73%
22,817 $94,000
Q3 2020

Nov 12, 2020

BUY
$3.69 - $7.09 $1,151 - $2,212
312 Added 1.45%
21,787 $85,000
Q2 2020

Aug 14, 2020

BUY
$3.58 - $7.44 $22,836 - $47,459
6,379 Added 42.26%
21,475 $160,000
Q1 2020

May 15, 2020

SELL
$3.49 - $9.2 $3,563 - $9,393
-1,021 Reduced 6.33%
15,096 $68,000
Q4 2019

Feb 14, 2020

BUY
$6.27 - $11.41 $101,053 - $183,894
16,117 New
16,117 $148,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $35M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.